Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure

Circ J. 2008 Mar;72(3):364-9. doi: 10.1253/circj.72.364.

Abstract

Background: The aim of this study was to analyze the relationship between abnormal liver function tests (LFTs) coincident with heart failure (HF) exacerbation and subsequent long-term outcome in patients with chronic HF.

Methods and results: The study population consisted of 183 consecutive patients admitted for HF exacerbation with left ventricular ejection fraction < or =40%. Cox proportional hazard analysis revealed that serum total bilirubin (T-Bil) levels on admission (hazard ratio 1.896, p<0.001, 95% confidence interval 1.323-2.717), but not T-Bil at discharge or other LFTs, was an independent predictor of subsequent cardiac events after hospital discharge (cardiac death or readmission for HF exacerbation) The cardiac-event-free rates significantly decreased according to increasing tertiles of T-Bil stratified by the level of 0.7 and 1.2 mg/dl (p<0.001). T-Bil on admission had significant correlations with simultaneously-measured central venous pressure (CVP) (r=0.42, p<0.01) and cardiac index (CI) (r= -0.50, p<0.01). The patients demonstrating high CVP together with low CI showed significantly increased T-Bil compared with any other group.

Conclusions: Increased T-Bil coincident with cardiac decompensation predicts a worse long-term prognosis of CHF, presumably through the potential liability to both congestion and tissue hypoperfusion simultaneously when HF deteriorates.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Bilirubin / blood*
  • Biomarkers / blood
  • Blood Pressure / physiology
  • Chronic Disease
  • Female
  • Follow-Up Studies
  • Heart Failure / blood*
  • Heart Failure / diagnosis*
  • Heart Failure / physiopathology
  • Humans
  • Kaplan-Meier Estimate
  • Liver / metabolism
  • Liver / physiopathology
  • Liver Function Tests
  • Male
  • Middle Aged
  • Prognosis
  • Proportional Hazards Models
  • Retrospective Studies

Substances

  • Biomarkers
  • Bilirubin